Inhibition of BRD4-promoter interactions has been shown to suppress the expression of important cell growth and survival genes, resulting in cell cycle arrest and extensive apoptosis in ER+ breast cancer [12, 13], leukemia [9] and lymphoma [14] cells. Here, BRD4 is linked to breast cancer.